Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
34.60 +0.13 / +0.38%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.60 0.00 / 0.00%
 
Volume: 207.00

Today’s Trading

Previous close34.47
Today’s open34.37
Day’s range34.14 - 34.64
Volume252,233
Average volume (3 months)701,187
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-39.84%
Earnings growth (next 5 years)+13.17%
Revenue growth (last year)+26.92%
P/E ratio27.6
Price/Sales3.31
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.71+0.62%
TSROTESARO Inc-0.08-0.14%
CBPOChina Biologic Produ...+1.37+1.27%
INSYINSYS Therapeutics I...+2.08+3.63%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.42
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers